Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Matthew Link Insider Profile
4 Followers
Matthew Link, President at NuVasive, holds 663.55K shares in Sight Sciences (Ticker: SGHT), holds 82.59K shares in NuVasive (Ticker: NUVA), holds ― shares in FibroBiologics, Inc. (Ticker: FBLG). Most recently, Matthew Link Sold ― shares of Sight Sciences on Oct 21, 2024 for an estimated value of 244.56K.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+37.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Matthew Link holds in companies
Most Profitable Insider Trade
The most profitable trade made by Matthew Link
Matthew Link's Trading History
NuVasive
Jun 10, 2020
―
Uninformative Sell
201.00K
$3.28M
Sight Sciences
Oct 21, 2024
CCO
Informative Sell
244.56K
$2.37M
FibroBiologics, Inc.
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Matthew Link's performance on stock
You May Also Like
Matthew Link insider profile FAQ
What is the percentage of profitable transactions made by Matthew Link?
The percentage of profitable transactions made by Matthew Link is 100%.
What is the average return per transaction made by Matthew Link?
The average return per transaction made by Matthew Link is 37.70%.
What stocks does Matthew Link hold?
Matthew Link holds: NUVA, SGHT, FBLG stocks.
What was Matthew Link’s latest transaction?
Matthew Link latest transaction was an Informative Sell of $244.56K.
What was Matthew Link's most profitable transaction?
Matthew Link’s most profitable transaction was an Informative Sell of SGHT stock on October 18, 2024. The return on the trade was 40.20%.
What is Matthew Link's role in NuVasive?
Matthew Link's role in NuVasive is President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.